Mintz Steven
Serina Therapeutics, Inc. · Director
Mintz Steven is listed in filings as Director at Serina Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 16, 2024, including purchase activity. Recent filings connect the profile to Serina Therapeutics, Inc. (SER). The current snapshot covers public activity from Jun 27, 2024 to Sep 16, 2024. Reported amounts are shown as $38.8K to $11.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $17k2.7k shares | BuyAug 15, 2024 | $6.59 | $1.91 | |
| $12k1.8k shares | BuyAug 15, 2024 | $6.59 | $1.91 | |
| $11k1.6k shares | BuyAug 15, 2024 | $6.59 | $1.91 | |
| $10k1.5k shares | BuyAug 15, 2024 | $6.59 | $1.91 | |
| $8.9k1.4k shares | BuyAug 15, 2024 | $6.59 | $1.91 | |
| $23k2.6k shares | BuyJun 25, 2024 | $9.00 | $1.91 | |
| $48k5k shares | BuyJun 21, 2024 | $9.50 | $1.91 |